This case uniquely highlights the potential for even modest reductions in renal function caused by SGLT-2 inhibitors to contribute to BRASH syndrome in patients with chronic kidney disease, particularly when combined with diuretics. Here, SLC5A2 is linked to chronic kidney disease.